F432-0521 Screening compound: ethyl 4-{[1,3-dimethyl-2-oxo-6-(phenylsulfanyl)-2,3-dihydro-1H-1,3-benzodiazol-5-yl]sulfamoyl}benzoate

F432-0521 Screening compound: ethyl 4-{[1,3-dimethyl-2-oxo-6-(phenylsulfanyl)-2,3-dihydro-1H-1,3-benzodiazol-5-yl]sulfamoyl}benzoate
F432-0521 Screening compound: ethyl 4-{[1,3-dimethyl-2-oxo-6-(phenylsulfanyl)-2,3-dihydro-1H-1,3-benzodiazol-5-yl]sulfamoyl}benzoate alternative view

Chemical Structure Depiction of ChemDiv screening compound F432-0521
ethyl 4-{[1,3-dimethyl-2-oxo-6-(phenylsulfanyl)-2,3-dihydro-1H-1,3-benzodiazol-5-yl]sulfamoyl}benzoate

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F432-0521

Molecular Formula

C24H23N3O5S2 (C24 H23 N3 O5 S2)

Compound Name

ethyl 4-{[1,3-dimethyl-2-oxo-6-(phenylsulfanyl)-2,3-dihydro-1H-1,3-benzodiazol-5-yl]sulfamoyl}benzoate

IUPAC name

ethyl 4-{[13-dimethyl-2-oxo-6-(phenylsulfanyl)-23-dihydro-1H-13-benzodiazol-5-yl]sulfamoyl}benzoate

SMILES

CCOC(c(cc1)ccc1S(Nc(cc(c(N1C)c2)N(C)C1=O)c2Sc1ccccc1)(=O)=O)=O

InChI

InChI=1S/C24H23N3O5S2/c1-4-32-23(28)16-10-12-18(13-11-16)34(30,31)25-19-14-20-21(27(3)24(29)26(20)2)15-22(19)33-17-8-6-5-7-9-17/h5-15,25H,4H2,1-3H3

InChI Key

ASBGTRRPPZJNTD-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27128572

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

497.6

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

5.096

Distribution Coefficient, logD

5.085

Water Solubility, LogSw

-4.85

Polar Surface Area

78.357

Acid Dissociation Constant (pKa)

9.00

Base Dissociation Constant (pKb)

-2.34

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

16.70

F432-0521 in Drug Discovery

Included in Screening Libraries

Anti-Inflammatory Library (24602 compounds)

Anticancer Library (62698 compounds)

Antiviral Library (67538 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Aurora A-B Kinases Targeted Library (9426 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Immune system
  • Cancer
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Digestive system
  • Male
  • Female
  • Hemic and lymphatic
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with F432-0521 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F432-0521?
Check Price and Availability of F432-0521, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F432-0521 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F432-0521
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F432-0521
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F432-0521 available by request